A new study identifies a signaling molecule that plays a major role in radiation-induced intestinal damage. The research, published by Cell Press in the June issue of the journal Cell Stem Cell, may lead to new strategies ...
With major implications for long-duration space travel, a study from the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center demonstrates that the high-energy radiation found in space may lead to ...
Radioactive elements, or radionuclides, are well-established anticancer agents whose main limitation is that they kill healthy cells almost as easily as they do tumors. But because nanoparticles can be targeted to tumors, ...
With the help of tiny, transparent zebrafish embryos, researchers at the Kimmel Cancer Center at Thomas Jefferson University and Jefferson Medical College are hoping to prove that a microscopic nanoparticle can be part of ...
Kent State faculty and graduate students are among a team of physicists who recreated the material essence of the universe as it would have been mere microseconds after the Big Bang -- a quark-gluon plasma.
Scientists at the University of Liverpool have identified a new gene that causes the spread of cancer. Professor Philip Rudland, Dr Guozheng Wang and Dr Roger Barraclough from the University’s Cancer and Polio Research ...
Using transparent zebrafish embryos, researchers at Jefferson Medical College have shown that a microscopic nanoparticle can help fend off damage to normal tissue from radiation. The nanoparticle, a soccer ball-shaped, hollow, ...
Three young scientists in the University of York’s Department of Chemistry have developed a gel that could spare cancer patients some of the unpleasant and dangerous side-effects of radiotherapy. PhD students Andrew Wilson ...
New sensor systems being developed will help treat cancer and improve the accuracy and reliability of existing radiation treatments. They should help improve patient care and outcomes. The results will go straight to commercialisation ...
Ground-breaking results from researchers at Harvard Medical School and Massachusetts Institute of Technology (MIT), USA, disclosed at the 13th European Cancer Conference (ECCO) have shown for the first time that targeted ...
